Related Experiment Video
Updated: May 31, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Associated comorbidities in psoriasis and inflammatory bowel disease
1Clinical Research Program, Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Patients with psoriasis and inflammatory bowel disease (IBD) have higher rates of comorbidities like autoimmune thyroiditis, hepatitis, and diabetes compared to psoriasis-only patients. This highlights shared inflammatory pathways and genetic links in these conditions.
Area of Science:
- Immunology
- Gastroenterology
- Dermatology
Background:
- Psoriasis and inflammatory bowel disease (IBD) share known associations, but detailed comorbidity information remains limited.
- Understanding these comorbidities is crucial for comprehensive patient management.
Purpose of the Study:
- To investigate comorbidities in patients with both psoriasis and IBD.
- To compare these comorbidities with those in patients having psoriasis only.
- To analyze differences within the IBD cohort.
Main Methods:
- A cohort of 146 patients with psoriasis and IBD was compared to 146 patients with psoriasis only.
- Patients were matched for gender, ethnicity, and age.
- Data included socio-demographics, comorbidities, and laboratory inflammation markers (CRP, ESR).
Main Results:
- Patients with both psoriasis and IBD showed significantly higher rates of autoimmune thyroiditis (6.8% vs 2.1%), hepatitis (6.2% vs 0.7%), and diabetes (26.7% vs 11.0%).
- Over 41% of patients with psoriasis and IBD were diagnosed with seronegative arthritis.
- Elevated C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) were observed in the psoriasis and IBD group.
Conclusions:
- Patients with co-occurring psoriasis and IBD experience a greater burden of comorbidities.
- Shared inflammatory pathways and genetic predispositions likely contribute to the development of these associated conditions.
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...